Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors
Introduction
Intravenous immunoglobulins (IVIg) have become an established component of immunomodulatory therapy in neurological autoimmune disorders, including inflammatory diseases of the central nervous system (CNS) (van der Meché and van Doorn, 1997, Dalakas, 1999, Stangel et al., 1999). In multiple sclerosis (MS), IVIg were shown in controlled studies to reduce the relapse rate and the number of gadolinium enhancing lesions (Fazekas et al., 1997, Achiron et al., 1998, Sorensen et al., 1998), and case reports also suggest a beneficial effect in acute disseminated encephalomyelitis (ADEM) (Hahn et al., 1996, Pradhan et al., 1999). Several mechanisms of action have been suggested from both in vivo and in vitro investigations, including modulation of the cytokine network, complement inhibition, and modification of B cell, T cell and monocyte functions (Andersson et al., 1996, Mouthon et al., 1996, Stangel et al., 1999). In experimental autoimmune encephalomyelitis (EAE), an animal model of inflammatory CNS disease, efficacy of IVIg was shown, and it was proposed that the effect is mediated by suppression of TNFα secretion and T cell modulation (Achiron et al., 1994, Pashov et al., 1998). However, there is no information on the immunomodulatory capacity of IVIg in the CNS. Activation of microglia, the principal immunological cell in the CNS, plays an important role in CNS inflammatory diseases (Brück et al., 1995, Sriram and Rodriguez, 1997). Upon stimulation, microglia produce a vast number of immunomodulatory substances like cytokines or nitric oxide (NO) (Spranger and Fontana, 1996, González-Scarano and Baltuch, 1999).
NO is a small molecule synthesized from the substrate l-arginine by the enzymatic reaction of NO synthases (NOS). Its role in vivo as messenger involves various functions during physiological and pathological processes (Lowenstein and Snyder, 1992, Schmidt and Walter, 1994). NOS can also be found in MS lesions, suggesting that NO may play a role in MS pathology (Bo et al., 1994, De Groot et al., 1997). Initially, NO was thought to be mainly toxic, and damage of oligodendrocytes by microglial NO has been suggested (Merrill et al., 1993). However, studies examining the role of NOS blockade in EAE are not conclusive (Parkinson et al., 1997, Kolb and Kolb-Bachofen, 1998), and recent investigations have shown that NO may even have a protective, anti-apoptotic effect under certain conditions (Nicotera et al., 1997, Dimmeler and Zeiher, 1997) or modulate the immune response (Kolb and Kolb-Bachofen, 1998). NO production was demonstrated to be downregulated in endothelial cells treated with IVIg (Schussler et al., 1996). We have therefore assessed in vitro the modulation of microglial NO production.
Section snippets
Cell culture
Microglia were isolated from neonatal Sprague–Dawley rat cerebra by the method of Giulian and Baker as previously described (Giulian and Baker, 1986, Hall et al., 1997). Briefly, brains were carefully stripped of the meninges and dissociated using mechanical shearing and trypsin (Sigma, Poole, UK). Cells were plated at two brains per polylysine (Sigma) coated 75-cm2 culture flask (Iwaki, Bibby-Sterilin, Stone, UK) in DMEM (Gibco, Paisley, UK) supplemented with 10% fetal calf serum (FCS;
Effect of IVIg and controls on the NO production of unstimulated microglia
Microglia are known to produce NO upon a variety of stimuli (Murphy et al., 1993). Under our experimental conditions, lipopolysaccharide (LPS, 1 μg/ml) was the most potent and reliable stimulator after treatment for 24 h (see Table 1). To verify that the measured nitrite indeed derived from NO production, the NOS inhibitor l-nitro-l-arginine-methyl ester (l-NAME, 1 mM) was used to block LPS-induced nitrite production. Interferon-γ (IFNγ, 100 U/ml) and phorbol myristate acetate (PMA, 1 μg/ml)
Discussion
We show here that IVIg can modulate microglial functions in vitro. While NO production was only enhanced in IFNγ stimulated cells, TNFα secretion was induced by IVIg alone and increased in stimulated microglia. Both of these effects are mediated through the Fc portion of IVIg. In contrast, Fc receptor mediated phagocytosis is inhibited by IVIg, probably due to blockade of the receptor. These differential effects demonstrate that there is not a general activation of microglia by IVIg and that
Acknowledgements
The study was partially supported by a research scholarship from the Deutsche Forschungsgemeinschaft (Sta 518/1-1) to M.S., and used facilities in the MRC Cambridge Centre for Brain Repair and the Universitätsklinikum Benjamin Franklin, FU Berlin.
References (63)
- et al.
Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo
Blood
(1994) - et al.
Impairment of TNF-receptor-1 signaling but not Fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice
Am. J. Pathol.
(1999) - et al.
Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide
Nitric Oxide
(1997) - et al.
Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
Lancet
(1997) - et al.
T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms
Trends Neurosci.
(1997) - et al.
Determination of nitrite/nitrate in human biological material by the simple Griess reaction
Clin. Chin. Acta
(1998) - et al.
β-interferon regulates the immunomodulatory activity of neonatal rodent microglia
J. Neuroimmunol.
(1997) A rapid and sensitive method allowing photometric determination of erythrophagocytosis by mononuclear phagocytes
J. Immunol. Methods
(1985)- et al.
Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator?
Immunol. Today
(1998) - et al.
Nitric oxide, a novel biologic messenger
Cell
(1992)
Apoptosis induction by macrophage-derived reactive oxygen species (ROS) in myelin-specific T cells requires cell–cell contact
J. Neuroimmunol.
Synthesis of nitric oxide in CNS glial cells
Trends Neurosci.
Nitric oxide: inducer or suppressor of apoptosis?
Trends Pharmacol. Sci.
Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis
J. Neurol. Sci.
NO at work
Cell
Human immunoglobulins inhibit thrombin-induced Ca2+ movements and nitric oxide production in endothelial cells
J. Biol. Chem.
Oligodendroglia are protected from antibody mediated complement injury by normal immunoglobulins (‘IVIg’)
J. Neuroimmunol.
Normal polyclonal immunoglobulins (‘IVIg’) inhibit microglial phagocytosis in vitro
J. Neuroimmunol.
Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation
J. Biol. Chem.
Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor α secretion
J. Clin. Invest.
Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses
Neurology
Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages
Clin. Exp. Immunol.
Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-α activity in human immunodeficiency virus type 1 infection
J. Infect. Dis.
Apoptosis of T lymphocytes in acute disseminated encephalomyelitis
Acta Neuropathol.
Stimulation of Fcg receptors in rat peritoneal macrophages induces the expression of nitric oxide synthase and chemokines by mechanisms showing different sensitivities to antioxidants and nitric oxide donors
J. Immunol.
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
Ann. Neurol.
Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures
Proc. Natl. Acad. Sci.
Phagocytosing ameboid microglial cells studied in a mouse corpus callosum slice preparation
Glia
Monocyte/macrophage differentiation in early multiple sclerosis lesions
Ann. Neurol.
A critical role for Syk in signal transduction and phagocytosis mediated by Fcg receptors on macrophages
J. Exp. Med.
Fc receptor biology
Annu. Rev. Immunol.
Cited by (48)
Nerve cells developmental processes and the dynamic role of cytokine signaling
2019, International Journal of Developmental NeuroscienceCitation Excerpt :Moreover, microglia likely represent important mediators of the relationship between maternal immune dysregulation and cytokine signaling impacting on neurodevelopment. Microglial cells, indeed, have been shown to respond to a variety of factors reaching the CNS through the bloodstream, including immunoglobulins (Stangel and Compston, 2001) and complement (McGeer and McGeer, 2002). They are recognized by dedicated receptors and trigger responses spanning from proliferation and migration to Ca2+ release and cytokine signaling (Garden and Möller, 2006).
A pivotal role of nonmuscle myosin II during microglial activation
2014, Experimental NeurologyCitation Excerpt :Supernatants from LPS-treated (50 ng/ml ± blebbistatin) microglia were analyzed for the amount of released TNFα by enzyme linked immunosorbent assay (ELISA) according to the protocol of the manufacturer (BD biosciences, San Diego, CA, USA). To investigate NO production by primary microglia we used the Griess reaction (Stangel and Compston, 2001). One hundred microliters of 50 ng/ml LPS-treated (± blebbistatin) microglia supernatants was mixed with equal volume of freshly prepared Griess reagent (0.2% naphtylethylen-diaminedihydrochloride + 2% sulfanilamid in 5% H3PO4; Merck, Darmstadt, Germany) in a 96-well plate and kept in the dark at room temperature for 15 min.
Nitric oxide/cyclic GMP signaling regulates motility of a microglial cell line and primary microglia in vitro
2014, Brain ResearchCitation Excerpt :Thus, BV-2 cells may serve as useful model in assays where robust microglial cell behavior is required. In macrophages, microglia, and endothelial cells LPS stimulation is accompanied by enhancing the synthesis level of iNOS, resulting in an increased release of NO (Arias-Salvatierra et al., 2011; Fiebich et al., 1998; Lieb et al., 2003; Maa et al., 2008; Stangel and Compston, 2001). Similar to primary microglia, BV-2 cells labeled for NADPH-diaphorase, a cytochemical marker for the presence of NOS (Fig. 3a and b).
Immunoglobulin G <inf>1</inf> immune complex upregulates interferon-γ-induced nitric oxide production via ERK1/2 activation in murine microglia
2012, Journal of NeuroimmunologyCitation Excerpt :Our study is consistent with the other previous studies showing that ERK activation induces NO production in glial cells as well as in macrophages (Bhat et al., 1998; Zhu et al., 2006) and IC activates ERK1/2 in both macrophages and microglia (Song et al., 2004; Luo et al., 2009). Previous report suggested that PI3K is involved in the production of NO when FcγR is activated (Stangel and Compston, 2001). However, in our system blocking PI3K pathway with wortmannin failed to abrogate NO production.
CCL5 induces a pro-inflammatory profile in microglia in vitro
2011, Cellular ImmunologyCitation Excerpt :After 24 h stimulation of primary rat microglia with chemokines in presence and absence of 10 ng/ml LPS, TNF-α release was measured by ELISA. LPS elevated TNF-α production as formerly shown [29], while the baseline soluble TNF-α amount was below the detection limit. However, as compared with medium control, chemokine co-stimulation did not significantly change TNF-α levels in the supernatants (Fig. 2B; Table 2).
Polyclonal immunoglobulins (IVIg) induce expression of MMP-9 in microglia
2009, Journal of Neuroimmunology